IPM Take
Cardiometabolic policy has spent decades telling people to eat better, move more and take their medicines. That advice is not wrong. It is just politically incomplete. A person cannot walk in a neighbourhood built for cars. They cannot eat well in a food desert. They cannot exercise safely in extreme heat. They cannot manage diabetes when poverty, housing, work schedules and fragmented care are stacked against them. The next phase of cardiometabolic prevention will be won or lost outside the consultation room.
Executive Summary
A 2026 review in Current Opinion in Clinical Nutrition and Metabolic Care argues that metabolic health should be reframed through climate change, urbanisation, physical activity, place and local knowledge. The paper highlights that neighbourhood design, transport infrastructure and climate effects such as extreme heat influence physical activity and metabolic processes, while greener neighbourhoods that support walking, cycling and public transport are associated with more favourable cardiometabolic outcomes.
The publication sits alongside a broader 2026 Lancet review on interventions for cardiometabolic multiple long-term conditions, which argues that prevention and management require population-level, individual-level and system-level interventions. A separate 2026 review in Current Opinion in Cardiology reinforces the role of community-based nutrition strategies, including fiscal policies, food environments, education, digital tools and “Food Is Medicine” programmes. Together, these publications point to a policy shift: cardiometabolic health cannot be treated as a lifestyle issue alone. It is increasingly an infrastructure, climate, equity and governance issue.
Why it matters
- Policymakers: Cardiometabolic prevention needs to be embedded into urban planning, transport, climate adaptation, food policy and social protection, not left only to health ministries.
- Public authorities: Cities and local governments may become frontline actors in metabolic health through green space, walkability, cooling infrastructure, active transport and healthier public procurement.
- Clinicians: Clinical advice on diet and exercise is weakened when patients live in environments that make healthy behaviour difficult, unsafe or unaffordable.
- Hospitals / providers: Integrated care models will be needed for people living with cardiometabolic multiple long-term conditions, especially where diabetes, obesity, cardiovascular disease, kidney disease and liver disease overlap.
- Patients / advocates: The debate must move away from blaming individuals and toward recognising how place, income, heat, housing, food access and transport shape metabolic risk.
- Civil society: Community knowledge, including Indigenous and local perspectives, can help design prevention models that are culturally relevant rather than imposed from above.
Cardiometabolic disease policy has a bad habit: it pretends prevention begins and ends with individual willpower.
Eat better. Move more. Lose weight. Take the medicine.
Those messages still matter. But a new cluster of 2026 publications suggests they are no longer enough.
A review published in Current Opinion in Clinical Nutrition and Metabolic Care argues that metabolic health needs to be widened beyond diet, clinical management and structured exercise. The paper reframes metabolic wellbeing through climate change, urbanisation, physical activity, place and local knowledge.
That sounds abstract. It is not.
It means a person’s metabolic risk is shaped by whether their neighbourhood has safe pavements, shade, parks, public transport, cycling routes, affordable healthy food, clean air and protection from extreme heat. It means obesity, diabetes and cardiovascular disease are not only biological or behavioural outcomes. They are also built into streets, housing systems, food markets and climate policy.
This is where cardiometabolic prevention becomes political.
For decades, health systems have pushed responsibility downward onto individuals. But individuals do not design cities. They do not set food prices. They do not regulate advertising. They do not decide whether a neighbourhood has green space or whether outdoor work continues during dangerous heat. They do not control whether primary care, pharmacy, nutrition support and specialist care are integrated or fragmented.
The 2026 Lancet review on cardiometabolic multiple long-term conditions makes a similar point from the health-system side. Cardiometabolic conditions often cluster because they share risk factors and biological pathways. Diabetes, cardiovascular disease, kidney disease, obesity and metabolic dysfunction-associated liver disease do not sit neatly in separate policy boxes. Yet many health systems still treat them through disease-specific pathways, separate budgets and disconnected clinics.
That fragmentation is expensive, inefficient and unfair.
Population-level measures, including fiscal, regulatory, environmental and screening policies, can improve risk factor identification and control. Individual-level interventions, including lifestyle support and pharmacotherapy, can reduce incidence and progression. System-level changes, including integrated care models and continuity of care, are needed to support people already living with multiple cardiometabolic conditions.
The policy message is blunt: no single intervention will carry the burden.
A third recent review, focused on nutritional interventions, reinforces this systems approach. Community-based nutrition programmes can reach underserved populations when they are culturally adapted and grounded in trust. Dietary patterns such as Mediterranean and DASH approaches can improve blood pressure, lipids and inflammation. But the review also points to policy tools such as taxes, nutrition labelling, healthier procurement standards, digital tools and “Food Is Medicine” programmes.
In other words, cardiometabolic prevention is no longer just about telling people what to eat. It is about changing what food systems make easy, affordable and normal.
This aligns with the 2025 WHO World Report on Social Determinants of Health Equity, which states that health outcomes are shaped by where people are born, grow, live, work and age, and by access to power, money and resources. WHO also warns that climate change damages social determinants of health and livelihoods unequally.
That matters because cardiometabolic disease is already distributed unequally.
Lower-income communities often face poorer food environments, less green space, unsafe streets, worse housing, higher heat exposure and weaker access to preventive care. These are not lifestyle failures. They are policy choices with metabolic consequences.
For IPM, the implication is clear.
The next generation of cardiometabolic prevention must connect clinical care with place-based policy. That means designing cities that make movement ordinary, food systems that do not punish low-income households, climate adaptation plans that protect people with metabolic and cardiovascular risk, and care models that treat cardiometabolic multimorbidity as the norm rather than the exception.
The future of metabolic health will not be decided only by new obesity drugs, glucose monitors or cardiology guidelines.
It will also be decided by pavements, trees, buses, school meals, housing, heat plans and whether governments finally admit that prevention is infrastructure.
